RHUMBLINE ADVISERS

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 1115418 BOSTON, MA

Position in NAUT

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$68,380

+$8,321 QoQ

Shares Held

36,567

-47.6% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 93 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 26% Shared 0% None 74%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. NAUT ranks #284 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$68,380	36,567	-47.6%	Shares	Sole	2026-08-12
2025-03-31	$60,059	69,755	-4.9%	Shares	Sole	2025-05-29
2024-12-31	$123,283	73,383	+3.5%	Shares	Sole	2025-05-29
2024-09-30	$202,025	70,886	-5.0%	Shares	Sole	2024-11-12
2024-06-30	$174,599	74,615	-0.3%	Shares	Sole	2024-08-01
2024-03-31	$220,082	74,858	+2.6%	Shares	Sole	2024-05-09
2023-12-31	$218,060	72,930	-1.6%	Shares	Sole	2024-02-08
2023-09-30	$234,235	74,125	+3.7%	Shares	Sole	2023-11-09
2023-06-30	$276,503	71,448	+0.9%	Shares	Sole	2023-08-08
2023-03-31	$196,060	70,780	+2.0%	Shares	Sole	2023-05-11
2022-12-31	$124,894	69,386	+0.6%	Shares	Sole	2023-02-14
2022-09-30	$146,267	68,994	+5.8%	Shares	Sole	2022-11-10
2022-06-30	$175,471	65,231	—	Shares	Sole	2022-08-11
No filing history on record for this holder in this stock.